EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, XFOR: X4 Pharmaceuticals Inc

24 Mar 26 15:59
LAST:

3.820

CHANGE:
 0.25		OPEN:
4.070		HIGH:
4.070		ASK:
0.000		VOLUME:
196.9K
CHG(%):
6.14		PREV:
4.070		LOW:
3.810		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Mar 264.0704.0703.8103.820196.9K
23 Mar 264.3404.3604.0004.070361.8K
20 Mar 264.1404.5004.1004.280684.9K
19 Mar 264.0104.1753.9204.170260.4K
18 Mar 264.1604.4203.9804.050559.1K
17 Mar 263.7504.2303.6294.230619.1K
16 Mar 263.6403.6953.5303.560443.1K
13 Mar 263.8804.0503.6803.690216.9K
12 Mar 264.2704.2703.8703.880308.4K
11 Mar 264.6304.6704.3104.330610.6K

PROFILE

Name:X4 Pharmaceuticals Inc
About:X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally bioavailable selective antagonist of chemokine receptor C-X-C chemokine receptor type 4 (CXCR4) for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. The company also develops mavorixafor that is in Phase 3 4WARD clinical trial to evaluate the efficacy, safety, and tolerability of oral, once-daily mavorixafor with or without stable doses of G-CSF in people with congenital, acquired primary autoimmune, or idiopathic CN who are experiencing recurrent and/or serious infections. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications; and with Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand. The company is headquartered in Boston, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:61 North Beacon Street, Boston, MA, United States, 02134
Website:https://www.x4pharma.com
CUSIP:98420X103
CIK:0001501697
ISIN:US98420X1037
FIGI:BBG001J1CYH8
LEI:549300R0UFVPXWP86U94

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:4.086.8%
MA10:4.014.9%
MA20:3.840.4%
MA50:3.683.7%
MA100:3.752.0%
MA200:3.2417.8%
STO9:27.66
STO14:20.47
RSI14:54.21
WPR14:-76.36
MTM14:0.12
ROC14:0.03 
ATR:0.38 
Week High:4.5017.8%
Week Low:3.635.3%
Month High:4.8326.4%
Month Low:3.1417.8%
Year High:6.6373.6%
Year Low:0.172,145.7%

RECENT SPLITS

Date Ratio
28 Apr 20251-30
14 Mar 20191-6